Ramipril Capsule
Product Images NDC 65862-477

This appears to be a graph showing the proportion of patients in a study who may have received a medication, likely ramipril, over the course of 1500 days of follow-up. The medication seems to have been associated with a reduction in some outcome, as the proportion of patients who experienced the outcome decreased over time, with a statistically significant difference (P=0.0001). However, without more information or context, it is not possible to determine the specifics of the study or the significance of the findings.*

This seems to be a table of data related to different medical conditions such as cardiovascular disease, diabetes, hypertension, etc. It also includes the number of patients in the study and incidence of a composite outcome in the placebo group. However, without understanding the context or objective of the study, it is difficult to provide a more detailed description.*

Each hard gelatin capsule contains 1.25 mg of Ramipril USP manufactured in India and distributed by Aurobindo Pharma USA, Inc. The medication is available only through prescription and must be kept away from children. The packaging includes a package insert for prescribing information as well as a code for tracking purposes. The capsules should be dispensed in a light-resistant, child-resistant container and stored in a controlled room temperature environment between 20°C to 25°C. Any dotted lines in the printing area should be ignored.*

Ramipril Capsules, USP, is a medication that comes in 100 capsules per bottle and is intended to be taken by prescription only. Each hard gelatin capsule contains 1.25 mg of Ramipril USP. The National Drug Code (NDC) of the product is 65862-474-10. The rest of the text appears to be either unintelligible or missing.*

Each capsule of Ramipril Capsules, USP contains 25mg of ramipril. This medication is distributed by Aurobindo Pharma USA, Inc. and has a unique national drug code of 65862-475-01. It is made in India and is only available via prescription. The medication should be kept in a tightly sealed container that has a child-resistant closure and stored at a temperature between 20°C and 25°C. For more information regarding the dosage and administration, the prescribing package insert should be read. The warning on the medication is to keep it out of the reach of children. However, if more details are required, additional information can be obtained through the code TS/DRUGS/19/1993. The dotted line at the bottom of the text is not to be printed, and the printing area is 45x15mm.*

Ramipril Capsules, USP, are sold in a package of 100 capsules (10X10 unit-dosage). Each hard gelatin capsule contains 2.5 mg of Ramipril USP. It is a prescription-only medication with NDA 65862-475-10. The rest of the text seems to be illegible or not relevant.*

This is a medication description for Ramipril, an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and heart failure. The medication is distributed by Aurobindo Pharma USA and comes in hard gelatin capsule form with each capsule containing 5mg of Ramipril. The dosage and administration instructions, as well as prescribing information, can be found in the package insert. The medication should be kept out of reach of children and stored in a light-resistant, tight container with child-resistant closure at a temperature of 20-25°C (68-77°F). Additional details regarding the printing and coding zones are also provided.*

Ramipril Capsules, USP, are available in a bottle of 100 capsules (10 x 10 Unit-dose). Each hard gelatin capsule contains Ramipril USP 5mg. The prescription drug is identified by National Drug Code (NDC) 65862-476-10 and manufactured by Aurobindo. The listed dosage form in the description is a capsule that is intended for oral administration and can only be acquired through prescription. The other texts are either unreadable or irrelevant to product information.*

Ramipril Capsules, USP is a prescription drug supplied by Aurobindo Pharma USA, Inc. It is available in a pack of 100 capsules, each containing Ramipril USP. The capsule's dosage and administration should be followed as per the package insert for prescribing information. The drug should be kept out of reach of children, in light-resistant, tight containers with a child-resistant closure. You should store it at 20° to 25°C (68° to 77°F), and the USP-controlled room temperature should be followed. The code written on the package is TS/DRUGS/19/1993.*